Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director · President and CEO | October 12, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,108 |
Reported balance
After 2026-10-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-12 · Tax withholding · Disposed 2,675 · Balance 191,108 F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 158,776 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 158,776 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person.
F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 14, 2021 Filed Jan 28, 2021 23:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,591 | $2.15 | $3,420.65 |
DisclosureSEC source: 0001654954-21-000909 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,225 F1 · shares: Represents shares withheld by the Issuer to satisfy tax withholding and remittance obligation in connection with the vesting of restricted stock units award, which was originally reported by the Reporting Person in Form 4 filed on July 15, 2020. This does not represent a sale by the Reporting Person. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 22:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-20-010846 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,816 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| August 14, 2020 Filed Aug 14, 2020 22:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 19,900 | $2.07 | $41,193.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,816 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.11, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 22:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $2.09 | $41,800.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,716 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.06 to $2.13, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 22:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $2.09 | $41,800.00 |
DisclosureSEC source: 0001654954-20-009211 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 638,716 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.06 to $2.14, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 14, 2020 Filed Jul 16, 2020 01:41 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 77,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-007751 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,716 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,746 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · derivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,746 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 84,254 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,254 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 782 | $1.93 | $1,509.26 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,091 Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 17:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 95,000 | $1.28 | $121,600.00 |
DisclosureSEC source: 0001654954-20-006997 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:50 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 6,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004349 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,873 Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:50 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 15,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-004349 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,926 F1 · shares: Represents shares of common stock issued for bonus. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 23:46 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-20-003758 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,015 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 17:11 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $1.62 | $32,400.00 |
DisclosureSEC source: 0001654954-20-003670 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.70, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 500 | $1.86 | $930.00 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,500 | $1.88 | $2,812.50 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,515 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 500 | $1.85 | $926.10 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 17,500 | $1.81 | $31,605.00 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,515 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| October 04, 2019 Filed Oct 7, 2019 22:15 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon stock | 17,322 | $1.61 | $27,888.42 |
DisclosureSEC source: 0001654954-19-011516 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| October 03, 2019 Filed Oct 7, 2019 22:15 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon stock | 2,678 | $1.69 | $4,523.68 |
DisclosureSEC source: 0001654954-19-011516 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,337 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 00:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-19-011384 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,015 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 22:38 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 40,000 | $1.42 | $56,880.00 |
DisclosureSEC source: 0001040470-19-000017 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.471, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 66,065 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000009 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,065 Underlying: Common Stock · 66,065 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:14 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 63,935 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000009 · primary_doc.xml · derivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,935 Underlying: Common Stock · 63,935 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 21:51 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001040470-19-000003 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,015 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| January 02, 2019 Filed Jan 2, 2019 23:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 171,667 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-19-000001 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 171,667 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 02, 2019 Filed Jan 2, 2019 23:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 171,667 | $0.59 | $101,283.53 |
DisclosureSEC source: 0001040470-19-000001 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:59 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 2,285 | $1.90 | $4,331.22 |
DisclosureSEC source: 0001040470-18-000049 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,348 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 00:09 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 19,003 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001040470-18-000044 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,003 Underlying: Common Stock · 19,003 shares Expires 2025-08-17 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 00:09 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 80,997 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001040470-18-000044 · primary_doc.xml · derivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,997 Underlying: Common Stock · 80,997 shares Expires 2025-08-17 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-18-000035 · primary_doc.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,667 Underlying: Common Stock · 30,000 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 30,000 | $0.59 | $17,700.00 |
DisclosureSEC source: 0001040470-18-000035 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $2.51 | $50,200.00 |
DisclosureSEC source: 0001040470-18-000035 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016, as amended on February 7, 2018. Read SEC document |
| May 09, 2018 Filed May 9, 2018 22:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option(right to buy) · Derivative | 25,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-18-000025 · primary_doc.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · PRESIDENT & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,667 Underlying: Common Stock · 25,000 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| May 09, 2018 Filed May 9, 2018 22:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 25,000 | $0.59 | $14,750.00 |
DisclosureSEC source: 0001040470-18-000025 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · PRESIDENT & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 9, 2018 22:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $2.32 | $46,400.00 |
DisclosureSEC source: 0001040470-18-000025 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · PRESIDENT & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016, as amended on February 7, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:59 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $0.99 | $2,958.00 |
DisclosureSEC source: 0001040470-18-000017 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,063 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| February 07, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · derivative · entry 6 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,667 Underlying: Common Stock · 25,000 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 07, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 25,000 | $0.59 | $14,750.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · nonDerivative · entry 5 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 7,500 | $2.50 | $18,750.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,000 | $2.56 | $2,560.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,563 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 9,500 | $2.51 | $23,845.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,563 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:30 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,000 | $2.52 | $5,040.00 |
DisclosureSEC source: 0001040470-18-000008 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 19:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-17-000084 · primary_doc.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,667 Underlying: Common Stock · 30,000 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 19:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 30,000 | $0.59 | $17,700.00 |
DisclosureSEC source: 0001040470-17-000084 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 19:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $3.40 | $67,940.00 |
DisclosureSEC source: 0001040470-17-000084 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $0.99 | $2,958.00 |
DisclosureSEC source: 0001040470-17-000069 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,063 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| August 10, 2017 Filed Aug 10, 2017 22:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001040470-17-000057 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,667 Underlying: Common Stock · 60,000 shares Expires 2019-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| August 10, 2017 Filed Aug 10, 2017 22:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 60,000 | $0.59 | $35,400.00 |
DisclosureSEC source: 0001040470-17-000057 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 8, 2017 22:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,700 | $3.70 | $9,990.00 |
DisclosureSEC source: 0001040470-17-000055 · primary_doc.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.